Chimerix Inc (NASDAQ:CMRX)
| 0.9701 Delayed Data As of Dec 07 |  0.0001 / +0.01%Today’s Change | 0.88 Today|||52-Week Range 2.27 | -47.84% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $89.3M |
Company Description
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Contact Information
Chimerix, Inc. 2505 Meridian Parkway Durham North Carolina 27713 |
Employees
Shareholders
| Mutual fund holders | 9.31% |
| Other institutional | 36.80% |
| Individual stakeholders | 19.65% |
Top Executives
| Michael T. Andriole | President & Chief Executive Officer |
| Thomas J. Riga | Chief Operating & Commercial Officer |
| Michelle LaSpaluto | Chief Financial Officer |
| Roy W. Ware | Chief Technology & Manufacturing Officer |
| Caryn Barnett | Vice President-Clinical Operations |
